Vir Biotechnology VIR
NASDAQ VIR
$10.64 -0.01 (-0.14%)
As of: Sep 30, 2026 · 9:42 AM EDT

Vir Biotechnology (VIR) Net Margin (2018 - 2026)

Updated

Vir Biotechnology (VIR) reported Net Margin of 33.51% for Q2 2026, up 9173.38 percentage points from -9139.87% a year earlier and up 433464.55 percentage points from the prior quarter.

Analysis

Vir Biotechnology (VIR) Net Margin (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vir Biotechnology's Net Margin came in at -82.98%, up 2812.96 percentage points year-over-year; for FY2025, it came in at -638.87%, up 64.53 percentage points from FY2024.

  • Net Margin has a five-year change of -247.79 percentage points (FY2020 to FY2025).
  • By year, Net Margin came in at -703.40% in FY2024 (+10.29 pp), -713.69% in FY2023 (-745.62 pp), 31.92% in FY2022 (-16.33 pp) and 48.25% in FY2021 (+439.34 pp).
  • The Q2 2026 figure ranks as the highest quarterly Net Margin since Q3 2022.
  • Year over year, Net Margin gained in two of the last eight quarters, with an average year-over-year change of -61242.62 percentage points.
  • The high point for year-over-year Net Margin in five years was Q2 2026 (a gain of 9173.38 percentage points); the low point was Q1 2026 (a drop of 429441.42 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -433431.03% (Q1 2026), -66.99% (Q4 2025) and -67975.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn 33.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.51%
Mar 31, 2026 -433,431.03%
Dec 31, 2025 -66.99%
Sep 30, 2025 -67,975.42%
Jun 30, 2025 -9,139.87%
Mar 31, 2025 -3,989.61%
Dec 31, 2024 -845.23%
Sep 30, 2024 -8,979.71%
Jun 30, 2024 -4,500.10%
Mar 31, 2024 -115.79%
Dec 31, 2023 -690.85%
Sep 30, 2023 -6,192.23%
Jun 30, 2023 -5,129.71%
Mar 31, 2023 -223.80%
Dec 31, 2022 -205.63%
Sep 30, 2022 46.81%
Jun 30, 2022 -188.27%
Mar 31, 2022 42.08%
Dec 31, 2021 64.63%
Sep 30, 2021 106.57%
API Access

Vir Biotechnology Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY